NASDAQ: ALMAlmonty Industries Inc Stock
$4.45-0.01 (-0.22%)
Updated Aug 29, 2025
ALM Price
$4.45
Fair Value Price
N/A
Market Cap
$871.58M
52 Week Low
$3.16
52 Week High
$5.15
P/E
N/A
P/B
114.16x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
29.17
Operating Cash Flow
N/A
Beta
1.48
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ALM's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Uranium
Industry Rating
F
ALM
Ranked#7 of 11
Ranked#7 of 11
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $77.39 | C | |
| $2.32 | C | |
| $2.38 | D |
Be the first to know about important ALM news, forecast changes, insider trades & much more!
ALM News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALM is poor value based on its book value relative to its share price (114.16x), compared to the US Uranium industry average (6.63x)
P/B vs Industry Valuation
ALM's short-term liabilities ($41.13M) exceed its short-term assets ($31.60M)
Short-term Liabilities Financials
ALM's long-term liabilities ($181.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more ALM due diligence checks available for Premium users.
Valuation
ALM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
114.16x
Industry
6.63x
ALM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ALM's financial health
Profit margin
Revenue
$5.2M
Net Income
-$42.5M
Profit Margin
-809.4%
Assets to liabilities
Assets
$230.4M
Liabilities
$222.7M
Debt to equity
29.17
ALM's short-term liabilities ($41.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALM's long-term liabilities ($181.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$9.7M
Investing
-$5.2M
Financing
$20.5M
ALM vs Uranium Stocks
Almonty Industries Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.